NEETPGAI
BlogPricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Pharmacology/Antacids, PPIs, H2 Blockers
    Antacids, PPIs, H2 Blockers
    hard
    pill Pharmacology

    A 52-year-old man with GERD is started on omeprazole 20 mg daily. After 3 days, he reports minimal symptom relief. His colleague, who takes famotidine 20 mg twice daily, reports complete relief within 1 hour of the first dose. Which pharmacokinetic feature explains why the PPI-treated patient must wait longer for symptom relief despite superior acid suppression?

    A. Omeprazole has a shorter half-life (1 hour) than famotidine (2.5–3.5 hours), requiring accumulation over multiple days
    B. Omeprazole requires hepatic activation to its active sulfenamide form, which accumulates in parietal cell canaliculi over 3–5 days before exerting irreversible inhibition
    C. Famotidine is absorbed in the proximal small intestine, whereas omeprazole is absorbed in the stomach, leading to faster gastric concentration
    D. Omeprazole undergoes extensive first-pass metabolism, reducing bioavailability to 30–40%, whereas famotidine has 40–50% bioavailability

    Explanation

    ## Why PPIs Have Delayed Onset Despite Superior Efficacy ### The Activation and Accumulation Paradox **Key Point:** PPIs are *prodrugs* that require an acidic environment and hepatic metabolism to be converted into their active form. This activation delay, combined with the need for accumulation in parietal cell canaliculi, explains the 3–5 day lag before maximal effect — even though the final inhibition is irreversible and more complete. ### Mechanism of PPI Activation 1. **Hepatic metabolism:** Omeprazole undergoes CYP3A4 and CYP2C19-mediated metabolism to form the active **sulfenamide** form. 2. **Acidic activation:** The sulfenamide is activated only in the acidic environment of the parietal cell canaliculus. 3. **Canalicular accumulation:** The active drug accumulates in the canaliculi over successive parietal cell secretory cycles. 4. **Irreversible binding:** Once activated, the sulfenamide forms a disulfide bond with cysteine residues on the H+/K+-ATPase, permanently disabling it. 5. **Steady state:** Full effect requires 3–5 days because new parietal cells must be synthesized to restore acid secretion capacity. ### Contrast with H2 Blockers **High-Yield:** H2 blockers (e.g., famotidine) are *not* prodrugs. They are absorbed intact, reach the parietal cell directly, and immediately block histamine H2 receptors. No activation step, no accumulation phase — hence rapid onset (30–60 minutes). ### Timeline Comparison ```mermaid flowchart TD A["Famotidine dose"]:::action --> B["Absorption in small intestine"]:::action B --> C["Rapid parietal cell uptake"]:::action C --> D["Immediate H2 receptor blockade"]:::action D --> E["Symptom relief: 30-60 min"]:::outcome F["Omeprazole dose"]:::action --> G["Hepatic CYP3A4/2C19 metabolism"]:::action G --> H["Sulfenamide formation"]:::action H --> I["Accumulation in parietal canaliculi"]:::action I --> J["Irreversible pump inhibition"]:::action J --> K["Maximal effect: 3-5 days"]:::outcome ``` **Clinical Pearl:** This is why PPI-naive patients with severe GERD or peptic ulcer disease are often given an H2 blocker or antacid *bridge* for the first few days while awaiting PPI steady state. ### Mnemonic **PPI = "Prodrug Puzzle"** — must be activated and accumulated before working. **H2 = "Hit Immediately"** — ready to block receptors right away. [cite:KD Tripathi 8e Ch 50]

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Pharmacology Questions